Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
23 Aug 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/08/23/2503212/0/en/Long-COVID-19-study-identifies-novel-blood-markers-as-potential-diagnostic-and-therapeutic-targets.html
09 Mar 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/03/09/2400311/0/en/Antisense-Therapeutics-to-present-poster-at-world-s-largest-NMD-conference.html
11 Jun 2020
// BUSINESSWIRE
https://www.businesswire.com/news/home/20200611005274/en/Antisense-Therapeutics-Announces-Poster-Presentation-Muscular-Dystrophy
21 May 2020
// BUSINESSWIRE
21 May 2020
// MARKETWATCH
https://www.marketwatch.com/press-release/antisense-atl1102-final-phase-ii-dmd-results-meet-primary-endpoint-and-exceed-expectations-on-secondary-endpoints-2020-05-21?mod=mw_more_headlines&tesla=y
17 Dec 2019
// BIO SPACE
https://www.biospace.com/article/releases/positive-results-reaffirm-plans-to-advance-atl1102-for-dmd-to-phase-iib-trial/?s=62
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE